BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 32546500)

  • 1. Advances in the diagnosis and management of IgG4 related disease.
    Lanzillotta M; Mancuso G; Della-Torre E
    BMJ; 2020 Jun; 369():m1067. PubMed ID: 32546500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging therapy options for IgG4-related disease.
    Lanzillotta M; Fernàndez-Codina A; Culver E; Ebbo M; Martinez-Valle F; Schleinitz N; Della-Torre E
    Expert Rev Clin Immunol; 2021 May; 17(5):471-483. PubMed ID: 33689549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical phenotypes of IgG4-related disease reflect different prognostic outcomes.
    Lanzillotta M; Campochiaro C; Mancuso G; Ramirez GA; Capurso G; Falconi M; Dagna L; Della-Torre E
    Rheumatology (Oxford); 2020 Sep; 59(9):2435-2442. PubMed ID: 32591828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgG4-related disease of the head and neck: CT and MR imaging manifestations.
    Fujita A; Sakai O; Chapman MN; Sugimoto H
    Radiographics; 2012; 32(7):1945-58. PubMed ID: 23150850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An update on IgG4-related lung disease.
    Morales AT; Cignarella AG; Jabeen IS; Barkin JS; Mirsaeidi M
    Eur J Intern Med; 2019 Aug; 66():18-24. PubMed ID: 31227290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgG4-related disease in the head and neck.
    Johnston J; Allen JE
    Curr Opin Otolaryngol Head Neck Surg; 2018 Dec; 26(6):403-408. PubMed ID: 30234659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgG4-related disease presenting as otogenic skull base osteomyelitis.
    Yim CD; An HJ; Ahn SK; Hur DG; Lee HJ
    Auris Nasus Larynx; 2021 Feb; 48(1):166-170. PubMed ID: 32111411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgG4-Related Disease Presenting as a Solitary Neck Mass.
    McKinnon T; Randazzo WT; Kim BD; Biddinger P; Forseen S
    J Radiol Case Rep; 2015 Feb; 9(2):1-8. PubMed ID: 25926922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgG4-Related Diseases in the Gastrointestinal Tract: Clinical Presentation, Diagnosis and Treatment Challenges.
    Backhus J; Seufferlein T; Perkhofer L; Hermann PC; Kleger A
    Digestion; 2019; 100(1):1-14. PubMed ID: 30384361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgG4-related autoimmune liver disease.
    Capurso G; Pedica F; Palumbo D; Della-Torre E
    Minerva Gastroenterol (Torino); 2023 Mar; 69(1):23-49. PubMed ID: 33267565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgG4-Related Disease With Testicular Involvement: A Case Report and Review of Literature.
    Wang G; Zhuo N; Luo X; Tian F; Wen Z; Li J
    Front Immunol; 2021; 12():717902. PubMed ID: 34447384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoglobulin G4-related diseases in the head and neck: a systematic review.
    Mulholland GB; Jeffery CC; Satija P; Côté DW
    J Otolaryngol Head Neck Surg; 2015 Jun; 44(1):24. PubMed ID: 26092582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [ENT and head and neck manifestations of the IgG4-related disease].
    Liard Y; Nigolian H; Lobrinus JA; Lenoir V; Becker M; Nieke JP; Seebach JD; Landis B; Guinand N
    Rev Med Suisse; 2020 Oct; 16(709):1870-1875. PubMed ID: 33026730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment and outcomes in patients with IgG4-related disease using the IgG4 responder index.
    Fernández-Codina A; Pinilla B; Pinal-Fernández I; López C; Fraile-Rodríguez G; Fonseca-Aizpuru E; Carballo I; Brito-Zerón P; Feijóo-Massó C; López-Dupla M; Cid MC; Martínez-Valle F; ; ;
    Joint Bone Spine; 2018 Dec; 85(6):721-726. PubMed ID: 29452298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [IgG4-related disease: about 3 cases].
    Abid H; Alaoui MEHHBE; Lamrani MYA; Figuigui M; Ahmed BC; Lahmidani N; Yousfi ME; Benajah DA; Maaroufi M; Abkari ME; Ibrahimi SA; Aqodad N
    Pan Afr Med J; 2020; 36():364. PubMed ID: 33235641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increase of circulating memory B cells after glucocorticoid-induced remission identifies patients at risk of IgG4-related disease relapse.
    Lanzillotta M; Della-Torre E; Milani R; Bozzolo E; Bozzalla-Cassione E; Rovati L; Arcidiacono PG; Partelli S; Falconi M; Ciceri F; Dagna L
    Arthritis Res Ther; 2018 Oct; 20(1):222. PubMed ID: 30285841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of immunoglobulin G4-related sialadenitis: outcomes of glucocorticoid therapy combined with steroid-sparing agents.
    Hong X; Zhang YY; Li W; Liu YY; Wang Z; Chen Y; Gao Y; Sun ZP; Peng X; Su JZ; Cai ZG; Zhang L; He J; Ren LM; Yang HY; Li ZG; Yu GY
    Arthritis Res Ther; 2018 Jan; 20(1):12. PubMed ID: 29382364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgG4-Related Disease and the Salivary Glands: A Review of Pathophysiology, Diagnosis, and Management.
    Skillington SA; Ogden MA
    Otolaryngol Clin North Am; 2021 Jun; 54(3):497-508. PubMed ID: 34024478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Perspectives on IgG4-Related Disease and Its Classification.
    Katz G; Stone JH
    Annu Rev Med; 2022 Jan; 73():545-562. PubMed ID: 34669430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on classification, diagnosis, and management of immunoglobulin G4-related disease.
    Chen Y; Cai S; Dong L; Umehara H
    Chin Med J (Engl); 2022 Jan; 135(4):381-392. PubMed ID: 34985023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.